IL16 and chronic obstructive pulmonary disease: Lower levels of IL16 (P  =  0.004) were observed in COPD patients compared with controls, whereas higher levels of STARD5 (P  =  3.22 × 10-9) and ME3 (P  =  0.044) were observed in COPD patients compared with controls.